Literature DB >> 8138562

An application of MIB antibody to the retrospective study of melanomas of oral mucosa and facial skin.

M Korabiowska1, U Brinck, J F Hoenig, S B Bartkowski, J Mirecka, A Schauer.   

Abstract

A new monoclonal antibody prepared against a fragment of Ki-67 antigen MIB, from Dianova, was applied for investigation of malignant melanomas of facial skin (25 cases) and the oral cavity (25 cases), which were routinely embedded in paraffin. The values of the Ki-67 index (expressed as a percentage of positive nuclei) were correlated with TNM characteristics of tumors and patient survival. Significant correlation was found between the Ki-67 index and the level of lymph node involvement (N value), the presence of distant metastases and the time of patient survival. A positive relationship between the Ki-67 value and tumor size was also observed although it lacked statistical significance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138562     DOI: 10.1007/bf01247462

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  16 in total

1.  Growth fraction in lung tumours determined by Ki67 immunostaining and comparison with AgNOR scores.

Authors:  I N Soomro; W F Whimster
Journal:  J Pathol       Date:  1990-11       Impact factor: 7.996

2.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

3.  Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading.

Authors:  P Kaudewitz; O Braun-Falco; M Ernst; M Landthaler; W Stolz; J Gerdes
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

4.  Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.

Authors:  A Breslow
Journal:  Ann Surg       Date:  1970-11       Impact factor: 12.969

Review 5.  Oral malignant melanoma.

Authors:  R L Liversedge
Journal:  Br J Oral Surg       Date:  1975-07

6.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

7.  Proliferation antigens in cutaneous melanocytic tumors--an immunohistochemical study comparing the transferrin receptor and the Ki 67 antigen.

Authors:  H P Soyer; J Smolle; F M Smolle-Juettner; H Kerl
Journal:  Dermatologica       Date:  1989

8.  The pathology of head and neck tumors: mucosal melanomas, part 13.

Authors:  J G Batsakis; J A Regezi; A R Solomon; D H Rice
Journal:  Head Neck Surg       Date:  1982 May-Jun

9.  Experience with malignant melanoma of the head and neck.

Authors:  J E Woods; E H Soule; J J Borkowski
Journal:  Plast Reconstr Surg       Date:  1978-01       Impact factor: 4.730

10.  An immunohistological method for estimating cell growth fractions in rapid histopathological diagnosis during surgery.

Authors:  J Gerdes
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

View more
  1 in total

Review 1.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.